General
Preferred name
OXITRIPTAN
Synonyms
5-hydroxy-L-tryptophan ()
L-5-HTP ()
L-oxitriptan ()
L-5-Hydroxytryptophan ()
Oxyfan ()
Tryptophan, 5-hydroxy-, dl ()
Levotinine ()
Dl-oxitriptan ()
Hydroxytryptophan ()
Triptene ()
Dl-hydroxytryptophan ()
Pretonine ()
5-hydroxy-l-tryptophan ()
Levothym ()
5-hydroxytryptophan, dl- ()
Cincofarm ()
Quietim ()
Levotonine ()
Telesol ()
5-hydroxytryptophan ()
Serotonyl ()
NSC-92523 ()
5-hydroxytryptophan l-form ()
Dl-5-htp ()
DL-5-Hydroxytryptophan ()
P&D ID
PD002706
CAS
4350-09-8
Tags
natural product
drug
available
Drug indication
Discovery agent
Drug Status
investigational
approved
nutraceutical
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS The psychoactive action of 5-HTP is thought to be due to increased serotonin production in central nervous system tissue.
METABOLISM 5-Hydroxytryptophan is decarboxylated to serotonin (5-hydroxytryptamine or 5-HT) by the enzyme aromatic-L-amino-acid decarboxylase via a vitamin B6 dependent reaction in nervous tissue and in the liver.
DESCRIPTION Serotonin precursor; antidepressant; anti-epileptic (LOPAC library)
Compound Sets
22
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Enamine BioReference Compounds
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
220.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
4
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
0.83
TPSA
99.34
Fraction CSP3
0.18
Chiral centers
1.0
Largest ring
6.0
QED
0.62
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Amino Acids and Derivatives
SLC36A1, SLC36A2
Endogenous Metabolite
Indication
insomnia
MOA
neurotransmitter
Pathway
Metabolic Enzyme/Protease
Source data